1-1 of 1
Authors: Barbara Fuller
Sort by
Journal Article
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer Free
Mitchell S. Anscher and others
The Oncologist, Volume 26, Issue 2, February 2021, Pages 139–146, https://doi.org/10.1002/onco.13585
Published: 17 November 2020
Advertisement
Advertisement